Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Double-blind Randomized Controlled Trial of Systemic Corticosteroid Therapy in AECOPD Patients Admitted to Hospital With Higher Blood Eosinophil Levels

NCT05059873 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT05059873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05059873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Double-blind Randomized Controlled Trial of Systemic Corticosteroid Therapy in AECOPD Patients Admitted to Hospital With Higher Blood Eosinophil Levels
Lead sponsor
Capital Medical University
Phase
Phase 4
Overall status
Terminated
Start date
March 5, 2023
Completion date
May 31, 2024
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute exacerbation of copd, blood eosinophil count, copd, corticosteroid, lung diseases, obstructive, morality, pulmonary disease, chronic obstructive